WHO Dengue Classification (2009) and Diagnostic Criteria

Classification Overview

• The World Health Organization (WHO) 2009 classification groups dengue infection into three clinical categories—dengue without warning signs, dengue with warning signs, and severe dengue—to guide triage and management decisions. 1

Clinical Categories

Dengue without Warning Signs

• Represents a mild febrile illness characterized by fever, headache, retro‑orbital pain, myalgia, arthralgia (often back pain), and rash; most patients can be managed as out‑patients. 2, 3, 4, 5

Dengue with Warning Signs

• The presence of any of the following warning signs—abdominal pain, persistent vomiting, fluid accumulation, mucosal bleeding, lethargy, liver enlargement, or a rising hematocrit concurrent with falling platelet count—signals the need for closer observation and hospital admission. 1

Severe Dengue

• Defined by one or more of: severe plasma leakage, severe bleeding, or organ failure (including shock, respiratory distress, severe hemorrhage, or other organ impairment); these patients require intensive care and aggressive fluid management. 1

Historical Comparison (1997 WHO Classification)

• Classic dengue fever was described as a mild febrile illness under the 1997 scheme. 2, 3, 4, 5
• Dengue hemorrhagic fever (DHF) required: fever, bleeding manifestations, thrombocytopenia (≤ 100 000 cells/µL), and plasma leakage with hemoconcentration (≥ 20 % rise in hematocrit). 6, 7, 8, 9
• Dengue shock syndrome (DSS) added to DHF criteria the presence of hypotension or a narrow pulse pressure (≤ 20 mm Hg). 6, 7, 8, 9

Diagnostic Laboratory Methods

• Molecular testing: Reverse‑transcription PCR provides reliable confirmation when performed ≤ 7 days after symptom onset. 2, 3, 4, 5
• Serologic testing: IgM capture ELISA becomes positive > 5–7 days after symptom onset and is useful for later confirmation. 10

Dengue Clinical Definitions and Diagnostic Timing (Cited Evidence)

Warning Signs (2009 WHO Classification)

• Persistent vomiting is recognized as a warning sign for dengue with warning signs, indicating the need for closer observation and possible hospital admission. 11

1997 WHO Classification Definitions

• Classic dengue fever (DF) was defined in the 1997 WHO system as the mild febrile‑illness category. [12][11]
• Dengue hemorrhagic fever (DHF) required fever, bleeding manifestations, thrombocytopenia (≤100,000 /mm³), and plasma leakage with hemoconcentration (≥20 % rise in hematocrit). [12][11]
• Dengue shock syndrome (DSS) added hypotension or a narrow pulse pressure (≤20 mm Hg) to the DHF criteria. [12][11]

Molecular Diagnostic Timing

• Reverse‑transcriptase polymerase chain reaction (RT‑PCR) can reliably detect dengue virus RNA in serum from approximately 2 days before symptom onset up to 7 days after onset. 13

WHO Dengue Classification: Evidence‑Based Recommendations

Warning Signs and Clinical Management

• The presence of fluid accumulation (e.g., pleural effusion or ascites) is one of the defined warning signs that warrants hospital admission and close observation in patients with dengue, according to the WHO 2009 classification. 14

Practical Implications for Resource‑Limited Settings

• The 2009 WHO dengue classification is considered more practical for triage decisions in resource‑limited environments, facilitating rapid identification of patients who may require higher‑level care. 14

Laboratory Testing in Endemic Areas

• In regions where dengue and Zika viruses co‑circulate, both molecular (RT‑PCR) and serologic (IgM ELISA) testing should be performed for dengue and Zika to account for overlapping clinical presentations, as recommended by the CDC’s MMWR Guidelines. 15